Mandate

VINGE ADVISES SBAB IN CONNECTION WITH ACQUISITION OF BOOLI

December 11, 2015

Vinge has advised SBAB in connection with the acquisition of the entire issued share capital in Booli Search Technologies AB (“Booli”). Completion in respect of 67% of the shares will take place in January 2016 and it is intended that the remaining 33% will be acquired subsequently. Booli develops products and services directed to the housing market. The services include, among other things, booli.se, one of Sweden’s largest search sites for residential properties with more than 270 000 unique visitors per week, and Hittamäklare.se, an estate agents comparison site for private individuals wishing to sell their residence. Booli will be a subsidiary of SBAB and will continue as an independent enterprise under the trademark Booli.

Vinge’s team consisted of partner Daniel Rosvall together with, among others, associates Maria Dahlin, Manne Bergström, Karin Virding, Tomas Forsgren, Karin Isacson and Niklas Thorgerzon as well as project assistants Anna Hellof and Caroline Skymberg.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026